Drug Master Files for: rivastigmine
✉ Email this page to a colleague
rivastigmine Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
17064 | A | II | 12/29/2003 | CIPLA LTD | RIVASTIGMINE TARTRATE USP |
17249 | A | II | 3/19/2004 | DR REDDYS LABORATORIES LTD | RIVASTIGMINE HYDROGEN TARTRATE |
17289 | A | II | 4/6/2004 | SUN PHARMACEUTICAL INDUSTRIES LTD | RIVASTIGMINE TARTRATE USP |
20227 | A | II | 1/29/2007 | ERREGIERRE SPA | RIVASTIGMINE TARTRATE |
20753 | A | II | 8/6/2007 | ORCHID PHARMA LTD | RIVASTIGMINE TARTRATE |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information